We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.
- Authors
Rolland, Morgane; Tovanabutra, Sodsai; deCamp, Allan C.; Frahm, Nicole; Gilbert, Peter B.; Sanders-Buell, Eric; Heath, Laura; Magaret, Craig A.; Bose, Meera; Bradfield, Andrea; O'Sullivan, Annemarie; Crossler, Jacqueline; Jones, Teresa; Nau, Marty; Kim Wong; Hong Zhao; Raugi, Dana N.; Sorensen, Stephanie; Stoddard, Julia N.; Maust, Brandon S.
- Abstract
We analyzed HIV-1 genome sequences from 68 newly infected volunteers in the STEP HIV-1 vaccine trial. To determine whether the vaccine exerted selective T cell pressure on breakthrough viruses, we identified potential T cell epitopes in the founder sequences and compared them to epitopes in the vaccine. We found greater distances to the vaccine sequence for sequences from vaccine recipients than from placebo recipients. The most significant signature site distinguishing vaccine from placebo recipients was Gag amino acid 84, a site encompassed by several epitopes contained in the vaccine and restricted by human leukocyte antigen (HLA) alleles common in the study cohort. Moreover, the extended divergence was confined to the vaccine components of the virus (HIV-1 Gag, Pol and Nef) and not found in other HIV-1 proteins. These results represent what is to our knowledge the first evidence of selective pressure from vaccine-induced T cell responses on HIV-1 infection in humans.
- Subjects
AIDS vaccines; VACCINATION complications; GENOMES; T cells; EPITOPES; PLACEBOS; AMINO acids; HLA histocompatibility antigens
- Publication
Nature Medicine, 2011, Vol 17, Issue 3, p366
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm.2316